Bioventures Investors, based in Wellesley, Massachusetts, is a venture fund established in 1998. The fund, led by Partner Peter Feinstein, focuses on Pre-Seed to Series D stages, with a keen interest in Software, Mobile, SaaS, Consumer, and FinTech sectors. Bioventures Investors has made 37 investments and has seen 8 successful exits. The firm is dedicated to advancing technology in life sciences and healthcare. For more details, visit their website: www.bioventuresinvestors.com.